Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ripasudil with or without descemetorhexis for corneal edema due to endothelial dysfunction
MOH_2018-03-01_002225Phase 4Not yet recruiting
- Sponsor
- פרופ' איגור קיזרמן
- Start
- Feb 2018
- Modality
- Recombinant Proteins and Enzymes, Peptides
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of glatiramer acetate and sodium chloride in corneal endothelial decompensation (3 arms), sponsored by פרופ' איגור קיזרמן. Planned start Feb 2018; status: not yet recruiting.
02
Drugs
glatiramer acetatesodium chloride
03
Conditions
corneal endothelial decompensation
Beyond the preview
Go deeper on MOH_2018-03-01_002225.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on MOH_2018-03-01_002225.